Cunningham, L., Kimber, I., Basketter, D. A., & McFadden, J. P. (2020). Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection. Autoimmun Rev.
Chicago Style CitationCunningham, Louise, Ian Kimber, David Arthur Basketter, i John Paul McFadden. "Why Judiciously Timed Anti-IL 6 Therapy May Be of Benefit in Severe COVID-19 Infection." Autoimmun Rev 2020.
Cita MLACunningham, Louise, Ian Kimber, David Arthur Basketter, i John Paul McFadden. "Why Judiciously Timed Anti-IL 6 Therapy May Be of Benefit in Severe COVID-19 Infection." Autoimmun Rev 2020.
Atenció: Aquestes cites poden no estar 100% correctes.